Truist Securities Maintains Buy on AdaptHealth, Lowers Price Target to $9

Benzinga Newsdesk www.benzinga.com Negative 70.9%

Neg 70.9% Neu 0% Pos 0%

Truist Securities analyst David Macdonald maintains AdaptHealth (NASDAQ:AHCO) with a Buy and lowers the price target from $14 to $9.